Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).
about
Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesityIncreased PAI-1 in females compared with males is protective for abdominal aortic aneurysm formation in a rodent model.Association between physical activity and markers of inflammation in a healthy elderly population.The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS)Effects of Two Different Dietary Patterns on Inflammatory Markers, Advanced Glycation End Products and Lipids in Subjects without Type 2 Diabetes: A Randomised Crossover Study.Diabetes is a proinflammatory state: a translational perspective.Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early lifePlasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment.Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease.The genetics of atherothrombotic disorders: a clinician's view.Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose toleranceHyperglycemia limits experimental aortic aneurysm progression.Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance.High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism.Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention programObesity, haemostasis and the fibrinolytic system.Level of proinsulin in association with cardiovascular risk factors and sleep snoring.Lipid abnormalities in the metabolic syndrome.Diet, nutrition and the prevention of type 2 diabetes.Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns.Acute effects of hyperinsulinemia and hyperglycemia on vascular inflammatory biomarkers and endothelial function in overweight and obese humans.Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies.Cardiovascular benefits of GLP-1-based herapies in patients with diabetes mellitus type 2: effects on endothelial and vascular dysfunction beyond glycemic control.Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.In type 2 diabetes patients, insulin glargine is associated with lower postprandial release of intact proinsulin compared with sulfonylurea treatment.Distribution and correlates of the metabolic syndrome in adults living in the San Juan Metropolitan Area of Puerto RicoInsulin resistance and cardiovascular disease: the role of PPARgamma activators beyond their anti-diabetic action.Whole grains and CVD risk.Peroxisome proliferator-activated receptor-gamma agonists for management and prevention of vascular disease in patients with and without diabetes mellitus.Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria.Metabolic syndrome and sleep apnea.Matrix biology of abdominal aortic aneurysms in diabetes: mechanisms underlying the negative association.The determinants of plasma plasminogen activator inhibitor-1 levels differ for American and Japanese men aged 40-49.Diabetes mellitus as a prothrombotic condition.Intracranial aneurysm formation in type-one diabetes ratsUse of insulin to improve glycemic control in diabetes mellitus.Low-grade chronic inflammation in the relationship between insulin sensitivity and cardiovascular disease (RISC) population: associations with insulin resistance and cardiometabolic risk profileBiological mechanisms of stroke prevention by physical activity in type 2 diabetes.Prevalence of overweight and obesity and their cardiometabolic comorbidities in Hispanic adults living in Puerto Rico.
P2860
Q28364491-F2C91406-06C2-4C7C-8FB4-6596136F282EQ30420161-59F540D1-AEA7-471A-B531-38F604CE8A3BQ31827702-01AA1D44-FDD8-4701-9720-8B2B3CAF6C4BQ33567573-1C575DCB-0A48-4078-80D6-06DA36B9B602Q33616622-4E2447C7-423B-4B04-B32D-B95F50E2EDADQ33693974-9E33AEE5-8C71-4C85-A2C3-F3D113388F82Q33735189-7CBD9FF0-D1D5-4DE0-B3A6-672CB6492EA5Q33812093-A9982CFE-6565-4841-8CFE-BAB829E013C4Q34001108-6E47617F-7691-4843-9FA4-F7D9BF689B01Q34215500-2FE7C61C-B482-481D-BB99-08DA36CCA6D4Q34225645-E1CB99AB-7D61-48A5-86C7-A5C435B68DE7Q34330589-2E973951-F6D1-4E77-8469-08A34B4EEE1CQ34367592-E64E591F-673D-4573-A86C-F526FCA19105Q34450673-01A225F2-EA10-43D8-962A-5EB4B68DBD4FQ34457386-398C5D20-F9AA-46D5-B5E4-CC0713AF4308Q34743382-38C00D65-04A7-4A5B-B2DD-3552E04F632AQ35064524-5415CF6C-2A3B-4992-AF42-6100F92FC948Q35087481-4B213281-E80D-488A-B581-4C34BE8825F6Q35670612-0FACD000-16E0-4214-A296-40C8BF8E97DEQ35829203-9426C7DF-478C-4250-A2BD-5FC896095030Q35859177-7F6E7341-9C46-42F5-B5EF-637CA5F4634CQ35905154-75155514-8683-4010-BB05-F106AC351728Q35936644-ED40A2B0-4F3D-4B95-A6B2-05E98BB47717Q35989396-34B348BF-7AE2-4F87-A56C-55D2CCBF846DQ36218262-2180800A-5936-48F2-A29F-A19498D5E4D2Q36228964-889A4DDE-AE0C-4289-9D73-3CC4384AED82Q36311427-C3DB60C2-EC36-46AE-8427-8FA01FDDCB18Q36319330-E85CF522-DF6C-4CF9-86EA-2CA1B1DB3EF5Q36379677-90382B83-96E9-4182-9B75-4D7DB07554ADQ36567768-D0AAE8F3-65E6-470F-8E3A-2A66C87E788AQ36662078-29C349DA-1C0C-4405-BBD2-DA4C837E0658Q36766101-2D4F13AA-2B42-4489-80ED-1819D2A099FDQ36830867-E4A5C90F-99E2-45F2-9704-5647347D3ABEQ36864352-88873962-8CDC-47F5-87BE-801BDC95DAF5Q36889156-B40B7AA5-E44E-472E-AA70-739C279EE3BDQ36976259-BD95C5FD-2DFB-46C8-89CB-87B9E4CBCF3DQ37112641-155E9F2D-9A00-4E45-A03D-2A6169A42B37Q37235932-A4483176-961F-4E0A-95DB-542282DD7CB1Q37242920-6A3C109F-1340-4840-BA15-98E837CFB54FQ37297161-0EC688C4-8AF1-4A85-B492-104466CC0204
P2860
Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Relative contribution of insul ...... Atherosclerosis Study (IRAS).
@en
Relative contribution of insul ...... sistance Atherosclerosis Study
@nl
type
label
Relative contribution of insul ...... Atherosclerosis Study (IRAS).
@en
Relative contribution of insul ...... sistance Atherosclerosis Study
@nl
prefLabel
Relative contribution of insul ...... Atherosclerosis Study (IRAS).
@en
Relative contribution of insul ...... sistance Atherosclerosis Study
@nl
P2093
P356
P1476
Relative contribution of insul ...... Atherosclerosis Study (IRAS).
@en
P2093
D'Agostino R Jr
Haffner SM
Mykkänen L
Zaccaro DJ
P304
P356
10.1161/01.ATV.19.3.562
P407
P577
1999-03-01T00:00:00Z